1	Lyphomed	_	NNP	_	_	16	SBJ	_	_
2	Inc.	_	NNP	_	_	1	POSTHON	_	_
3	,	_	,	_	_	1	P	_	_
4	Rosemont	_	NNP	_	_	1	APPO	_	_
5	,	_	,	_	_	4	P	_	_
6	Ill.	_	NNP	_	_	4	APPO	_	_
7	,	_	,	_	_	1	P	_	_
8	and	_	CC	_	_	1	COORD	_	_
9	Medco	_	NNP	_	_	10	NAME	_	_
10	Research	_	NNP	_	_	8	CONJ	_	_
11	Inc.	_	NNP	_	_	10	POSTHON	_	_
12	,	_	,	_	_	10	P	_	_
13	Los	_	NNP	_	_	14	NAME	_	_
14	Angeles	_	NNP	_	_	10	APPO	_	_
15	,	_	,	_	_	10	P	_	_
16	said	_	VBD	_	_	0	ROOT	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	Food	_	NNP	_	_	22	SBJ	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	Drug	_	NNP	_	_	21	NAME	_	_
21	Administration	_	NNP	_	_	19	CONJ	_	_
22	granted	_	VBD	_	_	16	OBJ	_	_
23	full	_	JJ	_	_	25	NMOD	_	_
24	marketing	_	NN	_	_	25	NMOD	_	_
25	approval	_	NN	_	_	22	OBJ	_	_
26	for	_	IN	_	_	25	NMOD	_	_
27	a	_	DT	_	_	29	NMOD	_	_
28	new	_	JJ	_	_	29	NMOD	_	_
29	drug	_	NN	_	_	26	PMOD	_	_
30	for	_	IN	_	_	29	NMOD	_	_
31	the	_	DT	_	_	32	NMOD	_	_
32	treatment	_	NN	_	_	30	PMOD	_	_
33	of	_	IN	_	_	32	NMOD	_	_
34	a	_	DT	_	_	35	NMOD	_	_
35	condition	_	NN	_	_	33	PMOD	_	_
36	in	_	IN	_	_	40	LOC	_	_
37	which	_	WDT	_	_	36	PMOD	_	_
38	the	_	DT	_	_	39	NMOD	_	_
39	heart	_	NN	_	_	40	SBJ	_	_
40	beats	_	VBZ	_	_	35	NMOD	_	_
41	between	_	IN	_	_	42	DEP	_	_
42	150	_	CD	_	_	45	NMOD	_	_
43	and	_	CC	_	_	42	COORD	_	_
44	200	_	CD	_	_	43	CONJ	_	_
45	beats	_	NNS	_	_	40	OBJ	_	_
46	a	_	DT	_	_	47	NMOD	_	_
47	minute	_	NN	_	_	45	ADV	_	_
48	.	_	.	_	_	16	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	condition	_	NN	_	_	10	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	known	_	VBN	_	_	2	APPO	_	_
5	as	_	IN	_	_	4	ADV	_	_
6	paroxysmal	_	JJ	_	_	8	NMOD	_	_
7	supraventricular	_	JJ	_	_	8	NMOD	_	_
8	tachycardia	_	NN	_	_	5	PMOD	_	_
9	,	_	,	_	_	2	P	_	_
10	leads	_	VBZ	_	_	0	ROOT	_	_
11	to	_	TO	_	_	10	ADV	_	_
12	dizziness	_	NN	_	_	11	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	fainting	_	NN	_	_	13	CONJ	_	_
15	.	_	.	_	_	10	P	_	_

1	The	_	DT	_	_	4	NMOD	_	_
2	typical	_	JJ	_	_	4	NMOD	_	_
3	healthy	_	JJ	_	_	4	NMOD	_	_
4	heart	_	NN	_	_	5	SBJ	_	_
5	beats	_	VBZ	_	_	0	ROOT	_	_
6	70	_	CD	_	_	7	NMOD	_	_
7	times	_	NNS	_	_	5	OBJ	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	minute	_	NN	_	_	7	ADV	_	_
10	.	_	.	_	_	5	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	drug	_	NN	_	_	7	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	called	_	VBN	_	_	2	APPO	_	_
5	adenocard	_	NN	_	_	4	OPRD	_	_
6	,	_	,	_	_	2	P	_	_
7	returns	_	VBZ	_	_	0	ROOT	_	_
8	the	_	DT	_	_	9	NMOD	_	_
9	heart	_	NN	_	_	7	OBJ	_	_
10	to	_	TO	_	_	7	ADV	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	normal	_	JJ	_	_	13	NMOD	_	_
13	rhythm	_	NN	_	_	10	PMOD	_	_
14	within	_	IN	_	_	7	TMP	_	_
15	seconds	_	NNS	_	_	14	PMOD	_	_
16	,	_	,	_	_	7	P	_	_
17	according	_	VBG	_	_	7	ADV	_	_
18	to	_	TO	_	_	17	PMOD	_	_
19	Lyphomed	_	NNP	_	_	18	PMOD	_	_
20	.	_	.	_	_	7	P	_	_

1	Medco	_	NNP	_	_	2	NAME	_	_
2	Research	_	NNP	_	_	3	SBJ	_	_
3	developed	_	VBD	_	_	0	ROOT	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	drug	_	NN	_	_	3	OBJ	_	_
6	and	_	CC	_	_	3	COORD	_	_
7	licensed	_	VBD	_	_	6	CONJ	_	_
8	it	_	PRP	_	_	7	OBJ	_	_
9	to	_	TO	_	_	7	ADV	_	_
10	Lyphomed	_	NNP	_	_	9	PMOD	_	_
11	for	_	IN	_	_	7	ADV	_	_
12	sale	_	NN	_	_	11	PMOD	_	_
13	in	_	IN	_	_	12	LOC	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	U.S.	_	NNP	_	_	13	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	Canada	_	NNP	_	_	16	CONJ	_	_
18	.	_	.	_	_	3	P	_	_

